- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD6563
Total 97 results
-
AstraZenecaQuintiles, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
AstraZenecaTerminatedSteatohepatitisUnited States, Puerto Rico
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
AstraZenecaCompleted
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
AstraZenecaCompletedGlucose LoweringUnited States
-
AstraZenecaCompletedHealthy VolunteersUnited States
-
AstraZenecaNot yet recruitingHealthy ParticipantsUnited States
-
AstraZenecaParexelRecruitingHealthy VolunteersUnited States, Germany
-
St George Street CapitalCompletedCovid19Czechia, Romania, United Kingdom
-
AstraZenecaCompleted
-
AstraZenecaRecruitingInflammatory DiseasesUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaNational Institute of Mental Health (NIMH)CompletedTreatment Resistant Major Depressive DisorderUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Queen Mary University of LondonAstraZenecaActive, not recruitingDiabetes Mellitus, Type 2 | End Stage Renal Disease | Type 2 Diabetes | Renal Transplant | Kidney Transplant; ComplicationsUnited Kingdom
-
AstraZenecaCompletedPharmacokinetics | Healthy Participants | Tolerability | SafetyUnited States
-
AstraZenecaParexelCompletedPulmonary/Respiratory DiseasesUnited States
-
AstraZenecaCompleted
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
AstraZenecaCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedMajor Depressive DisorderUnited Kingdom
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Adenocarcinoma | Gastro-esophageal Junction CancerKorea, Republic of, United States, Japan, Taiwan, China, United Kingdom, Netherlands
-
University of NottinghamAstraZeneca; Cancer Research UK; National Cancer Research NetworkCompleted
-
AstraZenecaCompletedRheumatoid ArthritisGermany, United Kingdom
-
AstraZenecaWithdrawn
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
AstraZenecaCompletedPharmacokineticsUnited Kingdom
-
AstraZenecaCompletedType 2 DiabetesUnited States, India
-
AstraZenecaCompletedHealthy VolunteerUnited Kingdom
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
AstraZenecaCompletedNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | NASH | Fatty Liver, NonalcoholicUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...RecruitingIntracranial Meningioma | Recurrent Meningioma | NF2 Gene MutationUnited States
-
AstraZenecaCompletedType II DiabetesUnited States